Atlas Lithium Corporation has received the expansion permit for its Neves Project in Minas Gerais, Brazil, enabling the company to advance production plans. The project’s Definitive Feasibility Study shows strong economics with an expected annual output of 146,000 tonnes of lithium concentrate, a 145% after-tax IRR, and an 11-month payback period. The company’s modular lithium processing plant is ready for assembly, and the project emphasizes environmental sustainability with low water use and dry-stacked tailings. This milestone supports Atlas Lithium’s position as a leading lithium developer with the largest exploration footprint in Brazil and backing from major investors like Mitsui & Co.
The global reactive hot melt adhesives market is projected to grow from $2.02 billion in 2025 to $4.29 billion by 2035, at a CAGR of 7.72%. Growth is driven by regulations limiting solvent-based adhesives, increased use of polyurethane adhesives in a...
The global automotive microcontrollers market is projected to grow from USD 15.49 billion in 2025 to USD 34.31 billion by 2035, at a CAGR of 8.28%. Growth is fueled by increasing adoption of advanced driver-assistance systems (ADAS), vehicle electrif...
CHARBONE Corporation has increased its helium delivery fleet from one to five units to meet rising demand caused by global helium supply disruptions, notably from Qatar. This expansion supports North American customers in sectors like semiconductors ...
Citi has started coverage of Hikma Pharmaceuticals with a 'buy' rating and a £17 price target, highlighting the company's strategic shift towards differentiated products and US manufacturing investments. The broker sees a 14% potential share price re...
Xenon Pharmaceuticals is evolving into a late-stage, cash-rich neuroscience company with a validated Kv7 potassium channel platform. Its lead drug candidate, azetukalner, has shown strong effectiveness in treating refractory focal onset seizures and ...
